These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 36092958)
41. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma. Liu J; Lu J; Li W BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159 [TBL] [Abstract][Full Text] [Related]
42. The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma. Wang W; Lu Z; Wang M; Liu Z; Wu B; Yang C; Huan H; Gong P Front Immunol; 2022; 13():998236. PubMed ID: 36110851 [TBL] [Abstract][Full Text] [Related]
43. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma. Guo YZ; Sun HH; Wang XT; Wang MT J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634 [TBL] [Abstract][Full Text] [Related]
44. Predicting the Immune Microenvironment and Prognosis with a NETosis-Related lncRNA Signature in Head and Neck Squamous Cell Carcinoma. He X; Xiao Y; Liu S; Deng R; Li Z; Zhu X Biomed Res Int; 2022; 2022():3191474. PubMed ID: 36147630 [TBL] [Abstract][Full Text] [Related]
45. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer. Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791 [No Abstract] [Full Text] [Related]
46. Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma. Liu B; Liu Z; Feng C; Li C; Zhang H; Li Z; Tu C; He S Front Endocrinol (Lausanne); 2022; 13():987942. PubMed ID: 36313774 [TBL] [Abstract][Full Text] [Related]
47. Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma. Yang L; Yu J; Tao L; Huang H; Gao Y; Yao J; Liu Z Front Genet; 2022; 13():947551. PubMed ID: 35938003 [No Abstract] [Full Text] [Related]
48. Cuproptosis-Related lncRNA Gene Signature Establishes a Prognostic Model of Gastric Adenocarcinoma and Evaluate the Effect of Antineoplastic Drugs. Tu H; Zhang Q; Xue L; Bao J Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553481 [TBL] [Abstract][Full Text] [Related]
49. Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints. Wang X; Chen D; Shi Y; Luo J; Zhang Y; Yuan X; Zhang C; Shu H; Yu W; Tian J Front Immunol; 2023; 14():1123231. PubMed ID: 37153542 [TBL] [Abstract][Full Text] [Related]
50. An original cuproptosis-related genes signature effectively influences the prognosis and immune status of head and neck squamous cell carcinoma. Zheng X; Zhang C; Zheng D; Guo Q; Maierhaba M; Xue L; Zeng X; Wu Y; Gao W Front Genet; 2022; 13():1084206. PubMed ID: 36685880 [No Abstract] [Full Text] [Related]
51. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer. Song S; Zhang M; Xie P; Wang S; Wang Y Front Immunol; 2022; 13():978909. PubMed ID: 36341328 [TBL] [Abstract][Full Text] [Related]
52. Identification of cuproptosis-related patterns and construction of a scoring system for predicting prognosis, tumor microenvironment-infiltration characteristics, and immunotherapy efficacy in breast cancer. Li W; Zhang X; Chen Y; Pang D Front Oncol; 2022; 12():966511. PubMed ID: 36212436 [TBL] [Abstract][Full Text] [Related]
53. An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance. Han Y; Shi Y; Chen B; Wang J; Liu Y; Sheng S; Fu Z; Shen C; Wang X; Yin S; Li H Front Immunol; 2022; 13():961695. PubMed ID: 36389709 [TBL] [Abstract][Full Text] [Related]
54. A cuproptosis-related long non-coding RNA signature to predict the prognosis and immune microenvironment characterization for lung adenocarcinoma. Ma S; Zhu J; Wang M; Zhu J; Wang W; Xiong Y; Jiang R; Seetharamu N; AbrĂ£o FC; Puthamohan VM; Liu L; Jiang T Transl Lung Cancer Res; 2022 Oct; 11(10):2079-2093. PubMed ID: 36386454 [TBL] [Abstract][Full Text] [Related]
55. Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma. Pang Y; Wang Y; Zhou X; Ni Z; Chen W; Liu Y; Du W Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674979 [TBL] [Abstract][Full Text] [Related]
56. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma. Zhang F; Liu Y; Yang Y; Yang K BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731 [TBL] [Abstract][Full Text] [Related]
57. An immune-related seven-lncRNA signature for head and neck squamous cell carcinoma. Chen Y; Luo TQ; Xu SS; Chen CY; Sun Y; Lin L; Mao YP Cancer Med; 2021 Apr; 10(7):2268-2285. PubMed ID: 33660378 [TBL] [Abstract][Full Text] [Related]
58. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma. Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755 [TBL] [Abstract][Full Text] [Related]
59. Cuproptosis related genes associated with Jab1 shapes tumor microenvironment and pharmacological profile in nasopharyngeal carcinoma. Wang L; Wang D; Yang L; Zeng X; Zhang Q; Liu G; Pan Y Front Immunol; 2022; 13():989286. PubMed ID: 36618352 [TBL] [Abstract][Full Text] [Related]
60. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma. Mao R; Chen Y; Xiong L; Liu Y; Zhang T Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]